Stracker Travis H, Couto Suzana S, Cordon-Cardo Carlos, Matos Tulio, Petrini John H J
Molecular Biology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, Cornell University Graduate School of Medical Sciences, New York, NY 10021, USA.
Mol Cell. 2008 Jul 11;31(1):21-32. doi: 10.1016/j.molcel.2008.04.028.
The Mre11 complex (Mre11, Rad50, and Nbs1) and Chk2 have been implicated in the DNA-damage response, an inducible process required for the suppression of malignancy. The Mre11 complex is predominantly required for repair and checkpoint activation in S phase, whereas Chk2 governs apoptosis. We examined the relationship between the Mre11 complex and Chk2 in the DNA-damage response via the establishment of Nbs1(DeltaB/DeltaB) Chk2(-/-) and Mre11(ATLD1/ATLD1) Chk2(-/-) mice. Chk2 deficiency did not modify the checkpoint defects or chromosomal instability of Mre11 complex mutants; however, the double-mutant mice exhibited synergistic defects in DNA-damage-induced p53 regulation and apoptosis. Nbs1(DeltaB/DeltaB) Chk2(-/-) and Mre11(ATLD1/ATLD1) Chk2(-/-) mice were also predisposed to tumors. In contrast, DNA-PKcs-deficient mice, in which G1-specific chromosome breaks are present, did not exhibit synergy with Chk2(-/-) mutants. These data suggest that Chk2 suppresses the oncogenic potential of DNA damage arising during S and G2 phases of the cell cycle.
Mre11复合物(Mre11、Rad50和Nbs1)和Chk2参与了DNA损伤反应,这是抑制恶性肿瘤所需的一个可诱导过程。Mre11复合物主要在S期的修复和检查点激活中发挥作用,而Chk2则调控细胞凋亡。我们通过构建Nbs1(DeltaB/DeltaB)Chk2(-/-)和Mre11(ATLD1/ATLD1)Chk2(-/-)小鼠,研究了DNA损伤反应中Mre11复合物与Chk2之间的关系。Chk2缺陷并未改变Mre11复合物突变体的检查点缺陷或染色体不稳定性;然而,双突变小鼠在DNA损伤诱导的p53调控和细胞凋亡方面表现出协同缺陷。Nbs1(DeltaB/DeltaB)Chk2(-/-)和Mre11(ATLD1/ATLD1)Chk2(-/-)小鼠也易患肿瘤。相比之下,存在G1期特异性染色体断裂的DNA-PKcs缺陷小鼠,并未与Chk2(-/-)突变体表现出协同作用。这些数据表明,Chk2抑制了细胞周期S期和G2期期间产生的DNA损伤的致癌潜力。